| Elizabeth Aurelia Weilert, APRN FNP-C | |
|
24764 S 4090 Rd, Claremore, OK 74019 | |
| (918) 981-1869 | |
| Not Available |
| Full Name | Elizabeth Aurelia Weilert |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 24764 S 4090 Rd, Claremore, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225537277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 79027 (Oklahoma) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 79027 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ahs Pryor Hospital, Llc | 3072880624 | 10 |
| Southwest Medical Associates, Llc | 7214831114 | 291 |
| Ahs Oklahoma Physician Group Llc | 9436122496 | 298 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a twofold increase in the penetration of biologics in the moderate-to-severe population will drive the psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Exact Sciences Corp. today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.
The federal health department announced $1.5 billion in new grants Thursday for states to continue building their insurance exchanges under the Affordable Care Act. California, Delaware, Iowa, Kentucky, Massachusetts, Michigan, Minnesota, New York, North Carolina, Oregon and Vermont received funding -; either one-or multi-year awards based on their progress in creating the marketplaces.
› Verified 1 days ago
| Entity Name | Southwest Medical Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164491072 PECOS PAC ID: 7214831114 Enrollment ID: O20031121000724 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a twofold increase in the penetration of biologics in the moderate-to-severe population will drive the psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Exact Sciences Corp. today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.
The federal health department announced $1.5 billion in new grants Thursday for states to continue building their insurance exchanges under the Affordable Care Act. California, Delaware, Iowa, Kentucky, Massachusetts, Michigan, Minnesota, New York, North Carolina, Oregon and Vermont received funding -; either one-or multi-year awards based on their progress in creating the marketplaces.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Aurelia Weilert, APRN FNP-C 24764 S 4090 Rd, Claremore, OK 74019-2298 Ph: (918) 981-1869 | Elizabeth Aurelia Weilert, APRN FNP-C 24764 S 4090 Rd, Claremore, OK 74019 Ph: (918) 981-1869 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a twofold increase in the penetration of biologics in the moderate-to-severe population will drive the psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Exact Sciences Corp. today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Signal Genetics, the parent company of Myeloma Health LLC, and Pronto Diagnostics Ltd, both of which are privately held predictive genetic testing companies focused on oncology, announced that they have entered into a Distribution Agreement whereby Pronto will be the exclusive representative and distributor for Signal's Myeloma Prognostic Risk Signature (MyPRS) test in Israel.
The federal health department announced $1.5 billion in new grants Thursday for states to continue building their insurance exchanges under the Affordable Care Act. California, Delaware, Iowa, Kentucky, Massachusetts, Michigan, Minnesota, New York, North Carolina, Oregon and Vermont received funding -; either one-or multi-year awards based on their progress in creating the marketplaces.
› Verified 1 days ago
Megan Diane Rasor, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1201 Parkland Ave, Claremore, OK 74017 Phone: 918-244-9175 | |
Mrs. Carol Sue Carter, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1926 S Highway 66, Claremore, OK 74019 Phone: 918-978-8900 | |
Mrs. Shannon Reavis, ARNP FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 21625 E 460 Rd, Claremore, OK 74019 Phone: 918-606-5702 | |
Melissa Nell Gingerich, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1501 N Florence Ave, Claremore, OK 74017 Phone: 918-579-3627 | |
Valerie Mitchell, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1501 N Florence Ave Ste 250, Claremore, OK 74017 Phone: 918-343-8513 | |
Linda A Meredith, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3001 W Blue Starr Dr, Claremore, OK 74017 Phone: 918-342-5432 Fax: 918-342-0835 | |
Arlene Maria Ann Siereveld, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3001 W Blue Starr Dr, Claremore, OK 74017 Phone: 918-342-5432 Fax: 918-342-0835 |